BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai BCG100
Menampilkan semua artikel
Until vaccines that are capable of protecting all populations against TB are developed, treatment is the best option to preventing infection.
South Africa’s long-awaited TB prevalence survey results were recently released. They reveal that the country has a much higher burden of TB than previously thought.
Tuberculosis is a global threat and a public health concern on a scale similar to COVID-19.
Kontributor teratas
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Senior Research Fellow, James Cook University
-
Professor of International Health at LSHTM and Member of Faculty, Africa Health Research Institute (AHRI)
-
Lead Senior Scientist, Aurum Institute
